Current reports
8-K
ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
28 Mar 24
8-K
Rapid improvements demonstrated for proptosis, clinical activity scores, and diplopia versus placebo with a favorable safety profile
20 Mar 24
8-K
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
11 Mar 24
8-K
Departure of Directors or Certain Officers
20 Dec 23
8-K
ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
27 Nov 23
8-K
ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
7 Nov 23
8-K
Departure of Directors or Certain Officers
21 Aug 23
8-K
ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
14 Aug 23
8-K
Departure of Directors or Certain Officers
2 Aug 23
8-K
ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
15 Jun 23
Registration and prospectus
S-8
Registration of securities for employees
28 Mar 24
S-8
Registration of securities for employees
8 May 23
424B4
Prospectus supplement with pricing info
5 May 23
S-1MEF
Registration of additional securities for an S-1
4 May 23
S-1/A
IPO registration (amended)
3 May 23
8-A12B
Registration of securities on exchange
2 May 23
S-1/A
IPO registration (amended)
1 May 23
S-1
IPO registration
13 Apr 23
DRS/A
Draft registration statement (amended)
24 Mar 23
DRSLTR
Correspondence regarding draft registration statement
24 Mar 23
Other
EFFECT
Notice of effectiveness
5 May 23
CERT
Certification of approval for exchange listing
4 May 23
SEC STAFF
SEC staff action: Order
4 May 23
CORRESP
Correspondence with SEC
2 May 23
CORRESP
Correspondence with SEC
2 May 23
CORRESP
Correspondence with SEC
20 Apr 23
CORRESP
Correspondence with SEC
13 Apr 23
UPLOAD
Letter from SEC
6 Apr 23
SEC STAFF
SEC staff action: Order
3 Apr 23
UPLOAD
Letter from SEC
15 Mar 23
Ownership
SC 13G
INTEGRATED CORE STRATEGIES (US) LLC
19 Apr 24
4
Shao-Lee Lin
3 Apr 24
SC 13G
AyurMaya Capital Management Company, LP
28 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
4
Shao-Lee Lin
22 Feb 24
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Shao-Lee Lin
11 Jan 24
4
Ronald Oyston
11 Jan 24